Dementia with Lewy bodies

British Journal of Psychiatry

Volumn 180, Issue FEB., 2002, Pages 144-147

  McKeith, Ian G ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLINESTERASE INHIBITOR; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; NEUROLEPTIC AGENT; RIVASTIGMINE;

ALZHEIMER DISEASE; AUTOPSY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PSYCHOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ANTIPSYCHOTIC AGENTS; CHOLINESTERASE INHIBITORS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEWY BODY DISEASE;

EID: 0036162885     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.180.2.144     Document Type: Review

References (12)

1. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging
2. Diffuse Lewy body disease: Clinical features in 15 cases
3. Clinical and quantitative pathologic correlates of dementia with Lewy bodies
4. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies
5. Operational criteria for senile dementia of Lewy body type (SDLT)
6. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
7. Rivastigmine in the treatment of dementia with Lewy bodies. Preliminary findings from an open trial
8. Efficacy of rivastigmine in dementia with Lewy bodies: Results of a randomised placebo-controlled international study
9. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: A preliminary study
10. The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia
11. In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies
12. Dementia associated with Lewy bodies